Ovid Therapeutics (OVID) Return on Capital Employed (QoQ) (2017 - 2026)
Ovid Therapeutics (OVID) Return on Capital Employed (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,516.00 |
| Dec 31, 2025 | 2,119.00 |
| Sep 30, 2025 | -515.00 |
| Jun 30, 2025 | 1,460.00 |
| Mar 31, 2025 | -225.00 |
| Dec 31, 2024 | -99.00 |
| Sep 30, 2024 | -869.00 |
| Jun 30, 2024 | -1,360.00 |
| Mar 31, 2024 | 23.00 |
| Dec 31, 2023 | -450.00 |
| Sep 30, 2023 | -199.00 |
| Jun 30, 2023 | -369.00 |
| Mar 31, 2023 | -172.00 |
| Dec 31, 2021 | 308.00 |
| Sep 30, 2021 | 629.00 |
| Jun 30, 2021 | -2,483.00 |
| Mar 31, 2021 | 21,422.00 |
| Dec 31, 2020 | 2,065.00 |
| Sep 30, 2020 | 4,624.00 |
| Jun 30, 2020 | -8,850.00 |